Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Impact on Quality of Life (QoL) of Persons with ME/CFS.

Muirhead, Nina L, Vyas, Jui, Ephgrave, Rachel et al. · Medicina (Kaunas, Lithuania) · 2024 · DOI

Quick Summary

This study surveyed 876 people with ME/CFS from 26 countries to understand how the condition affects their daily lives. People with ME/CFS reported very poor quality of life, with an average health rating of 36 out of 100. The most common problems were difficulty doing everyday activities (97%), pain (92%), and trouble with movement (83%).

Why It Matters

This large international study provides robust evidence of the profound impact ME/CFS has on patients' quality of life, challenging misconceptions that psychological factors dominate the condition. The findings support the recognition of ME/CFS as a serious physical illness characterized primarily by functional disability rather than psychiatric comorbidity.

Observed Findings

97% of participants reported inability to perform usual activities
92% reported pain
83% reported impaired mobility
64% reported difficulty with self-care
62% reported anxiety or depression
Mean overall health status: 36.4 on visual analogue scale (0-100)
Diagnostic delay averaged 14 years

Inferred Conclusions

ME/CFS significantly impairs quality of life across multiple domains globally, with functional limitation being the predominant problem rather than psychological symptoms
Anxiety and depression are less commonly reported than physical symptoms, contradicting the popular misconception that ME/CFS is primarily a psychiatric condition
Quality of life impact is consistent across different patient populations regardless of family member involvement

Remaining Questions

How does quality of life change over the disease course, and are there phenotypic differences between patients with varying severity levels?
What specific factors contribute to the 14-year diagnostic delay, and how does this delay affect long-term outcomes?
How do different treatment approaches or interventions affect quality of life trajectories in ME/CFS patients?
What is the impact of healthcare access, geographic location, and socioeconomic factors on quality of life outcomes in this population?

What This Study Does Not Prove

This cross-sectional survey cannot establish causation or temporal relationships between ME/CFS symptoms and quality of life decline. The study relies on self-reported diagnoses and online participation, which may introduce selection bias toward those with internet access and may not fully represent the most severely affected patients.

Metadata

DOI: 10.3390/medicina60081215
PMID: 39202496
Review status: Editor reviewed
Evidence level: Single-study or moderate support from human research
Last updated: 7 April 2026